logo

Canadian-led initiative urges parents to prioritize child eye exams to prevent long-term vision complications Français

Cision Canada22-05-2025
FYidoctors Shines a Light on Childhood Myopia During Myopia Awareness Week (May 19-25)
CALGARY, AB, May 22, 2025 /CNW/ - As Myopia Awareness Week approaches (May 19-25, 2025), FYidoctors is calling on Canadian families, and policymakers, to take simple but urgent steps to protect children's vision.
"We're at a turning point in how we understand and manage childhood myopia", said Dr. Alan Ulsifer, Founder, CEO and Chair of FYidoctors, "If left unchecked, myopia can lead to serious vision problems later in life. The good news is, we now have the tools and technology to slow that progression. At FYidoctors, we're proud to be at the forefront of this shift helping families take action early. With proactive care and the right interventions, we're not just correcting vision, we're protecting it for the long term."
With a steep increase in screen time and indoor learning, myopia (nearsightedness) is becoming increasingly common among school-aged children, who may not notice or report issues with their eyesight. Eye exams and early intervention can help prevent serious eye health issues later in life.
"I noticed one of my students squinting and struggling to keep up. I suggested an eye exam—they were diagnosed with myopia, and once they had glasses, they caught up quickly," said Sonia Hooda, elementary school teacher in Whitby, Ontario.
Recent research shows that the rate of myopia in Canadian children increases from 6 per cent among ages 6–8 to nearly 29 per cent by ages 11–13. Left unaddressed, myopia can lead to serious complications like retinal detachment, glaucoma, and cataracts in adulthood.
FYidoctors, a leading Canadian eye care provider, is using Myopia Awareness Week to urge families to prioritize children's eye exams – an often-overlooked part of routine care, despite most provinces, including Ontario, Alberta, British Columbia, and Quebec, offering complimentary annual exams for those under 19. They also aim to raise awareness about the availability of treatments that help slow the progression of myopia in children.
Making it even easier for families to monitor and protect their child's vision, FYidoctors is incorporating convenient, app-based tools like Ocumetra, a predictive platform that helps optometrists track and forecast eye development using biometric data. These data-driven insights allow parents and clinicians to detect changes early and take proactive steps to slow the progression of myopia. This technology reflects FYidoctors' broader commitment to innovation in preventative care, helping improve long-term outcomes and accessibility in children's vision health.
"Clear vision is not a luxury, it's a fundamental part of a child's ability to learn, socialize, and succeed," added Dr. Ulsifer. "We want to ensure families understand that myopia is both manageable and, in many cases, especially if detected early."
Since children often don't report vision issues, FYidoctors is amplifying its Better Sight. Better Grades. program, which offers complimentary eye exams and corrective eyewear for children in need. Teachers and educators can refer children to the program, helping ensure that vision problems don't stand in the way of a child's education.
To learn more about Myopia Awareness Week and how FYidoctors is supporting Canadian families through Better Sight. Better Grades., visit www.fyidoctors.com.
ABOUT FYihealth group
FYihealth group is Canada's leading diversified healthcare organization comprised of FYidoctors, Visique, BonLook, and solis optics. Doctor-led, professionally managed, and patient-focused, the organization concentrates on delivering outstanding eye care with patient-centric products and services. Recognized as one of Canada's Best Managed Companies from 2020-2025, the organization operates almost 400 clinic and store locations across the country. Rooted in a mission to enhance lives, FYihealth group supports a wide array of philanthropic causes and initiatives, including giving back to young optometrists through funding and partnerships with the University of Waterloo School of Optometry and Vision Science and the École d'optométrie de l'Université de Montréal. For more information, please visit www.fyihealthgroup.com
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Vital Materials Released Quantum Flux Photon Counting CT (PCCT) Full Vertical Integration Technology
Vital Materials Released Quantum Flux Photon Counting CT (PCCT) Full Vertical Integration Technology

Cision Canada

time3 hours ago

  • Cision Canada

Vital Materials Released Quantum Flux Photon Counting CT (PCCT) Full Vertical Integration Technology

BEIJING, Aug. 19, 2025 /CNW/ -- From August 15-17, the 31 st China International Medical Equipment Exhibition and Scientific Conference (China-Hospeq 2025) was held in Beijing. Vital Materials officially launched the VITA Genesis, China's fully proprietary Photon Counting CT (PCCT) scanner, marking the entry of global medical imaging technology into the "Quantum Flux" sensing era and empowering Chinese innovation in precision diagnostics and treatment. The Photon Counting Detectors (PCD), as the core technology of PCCT, differ significantly from traditional Energy Integrating Detectors (EID). Traditional CT scanners require X-ray photons to first be converted into visible light, then into electrical signals. In contrast, the PCCT detector employs semiconductor materials, where X-ray photons excite electrons, creating electron-hole pairs proportional to photon energy. Charge carriers from the pairs are separated by an electric field to generate electrical pulses. Application-Specific Integrated Circuits (ASIC) categorize these pulses by energy bins, enabling precise photon counting and energy resolution. This breakthrough provides crucial technical support for multi-energy spectral imaging, significantly enhancing the diagnostic value of medical imaging. Currently, the PCCT detectors primarily utilize three materials: Cadmium Zinc Telluride (CdZnTe or CZT), Cadmium Telluride (CdTe), and Deep Silicon. CZT is emerging as a breakthrough for next-generation medical imaging technology due to its outstanding detection capabilities. The core value of VITA Genesis lies not only in adopting a detector solution based on the CZT, but more importantly in pioneering the mastery of PCCT's full vertical integration technology. This includes ultra-high purity metals purification and compounding, single crystal growth and processing, component design and development, CT system integration, and imaging algorithm development, establishing a global paradigm in the field of PCCT.

MetricAid Announces Appointment of Board of Directors to Support Accelerated Growth and Global Expansion
MetricAid Announces Appointment of Board of Directors to Support Accelerated Growth and Global Expansion

Cision Canada

time9 hours ago

  • Cision Canada

MetricAid Announces Appointment of Board of Directors to Support Accelerated Growth and Global Expansion

NORTH BAY, ON, Aug. 19, 2025 /CNW/ - MetricAid is proud to announce the formal appointment of its new Board of Directors. This exceptional group of industry leaders brings unparalleled expertise across healthcare, technology, operations, and corporate governance - a significant milestone as the company enters its next phase of accelerated growth and international expansion. The newly appointed Board comprises: Paul Tsaparis, former Board Chair of York University, former CEO and President of Hewlett-Packard Canada and currently a board member of Teranet, Metrolinx and Indspire. Mr. Tsaparis is a recognized leader in Canadian technology and innovation with extensive board experience in both public and private sectors. His deep understanding of growth-stage companies is a tremendous asset to MetricAid's long-term success. Eugene Roman, former Chief Technology Officer of Canadian Tire and OpenText, current Executive-in-Residence at the Schulich School of Business for AI and a renowned figure in enterprise digital transformation. Mr. Roman brings decades of experience in IT strategy, cybersecurity, and large-scale systems architecture. Dr. Mark Schweitzer, internationally respected radiologist and current Special Associate for Public Health, is planning the New School of Public Health at Wayne State University. Dr. Schweitzer offers deep clinical insight and a global healthcare perspective that aligns with MetricAid's commitment to physician-centred scheduling. Dr. Schweitzer has published more than 400 peer-reviewed papers with more than 27000 citations. Mark Fam, President & CEO of Oak Valley Health, one of Canada's leading healthcare institutions. With extensive leadership in hospital operations, Mr. Fam strengthens MetricAid's strategic alignment with public health systems and complex care environments. Warren Urquhart, currently Governance Counsel for Toronto Hydro, is licensed to practice Law in Ontario and New York. Warren sits as a current member of the Publications Advisory Board of the International Association of Privacy Professionals, directing content and coverage of global privacy law and AI Governance developments. In addition, Warren is an executive of both the Canadian Bar Association and the Ontario Bar Association's Privacy and Access to Information Bar Executive. "The calibre of leadership now guiding MetricAid is a testament to both our past performance and our future ambitions," said Lora Webb, CEO of MetricAid. "We are thrilled to welcome directors whose influence spans global healthcare, world-class technology, and high-growth operations. We are more prepared than ever to shape the future of physician scheduling." MetricAid's mission: Revolutionize Emergency Medicine Scheduling For more information or to request interviews, please contact: About MetricAid

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store